Venue | Press Room | Subscribe | Site Map
TechConnect Summit 2006
Home | About the Summit | Program | Advisory Boards | About TechConnect

Producing Sponsor

TechConnect

Platinum Sponsor

Welsh & Katz, Ltd.

Gold Sponsor

ISTC International Science & Technology Center

Ventures Enabling Sponsor

Atomic Venture Partners

Press Sponsor

Business Wire

Partnering Sponsor

NSTI

Supporting Organizations

Boston University
Midwest Research University Network

Media Sponsors

(joint with Nanotech 2006) Nature
Science
R&D Magazine

Summit News

Event Contact

Jennifer Rocha
955 Massachusetts Ave. #313
Cambridge, MA 02139
Phone: (774) 249-8514

Carigent Therapeutics

Location:CT, US
Speaker:Peter Fong
Title:President
Primary Industry:Pharma & Biotech
Executive Summary:Carigent Therapeutics is a drug delivery company focused on the development and commercialization of innovative medical treatments utilizing its proprietary drug delivery technologies. Spun out of the Saltzman laboratory of biomedical engineering at Yale University, the company is leveraging a deep base of knowledge in the use of biodegradable polymers as well as proprietary surface modification technologies to create novel, nano-sized drug delivery platforms. Its founders include W. Mark Saltzman, Ph.D., chair of Yale’s biomedical engineering department, and represent decades of experience in the use of biodegradable polymers for drug delivery. They believe that Carigent is uniquely positioned to enter the injectables and targeted therapeutics markets with novel products and that the technology allows for a myriad of commercial opportunities by reformulating or improving the safety and efficacy of numerous drugs.
Venture is:Seed Level

 

Home | About the Summit | Program | Advisory Boards | About TechConnect
Terms of use | Privacy policy | Contact | TechConnect Home
© 2005 TechConnect. All rights reserved.